| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 08/12/2009 | CN101506208A Pyrrolo isoquinolines as kinase inhibitors |
| 08/12/2009 | CN100526317C Gambogicacid derivative and its preparation method and uses in pharmacy |
| 08/11/2009 | US7572824 Methods for minimizing thioamide impurities |
| 08/11/2009 | US7572807 3-Cycloheptyl-8-((2,6-dichlorophenoxy)methyl)H-imidazo[1,5-a]pyridine; N-((3-((2,6-Dichlorophenoxy)methyl)pyridin-2-yl)methyl)cycloheptane-carboxamide; diabetes; cardiovascular diseases, Metabolic Syndrome, inflammatory diseases |
| 08/11/2009 | US7572804 Macrolides |
| 08/11/2009 | US7572793 Tau protein kinase 1 inhibitors; treatment for neurodegenerative disorders; Alzheimer's Disease, Parkinson's disease, Pick's Disease, vision defects; antiischemic, antidiabetic, anticarcinogenic, antitumor agents, antidepressants |
| 08/11/2009 | US7572784 Inhibit Aurora kinase; cancer; 4-[9-Chloro-7-(2-fluoro-phenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-ylamino]-N-(2-methylamino-ethyl)-benzamide; 9-Chloro-N-(4-{[3-(dimethylamino)azetidin-1-yl]carbonyl}phenyl)-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-amine |
| 08/11/2009 | CA2564377C 6-o-substituted ketolides having antibacterial activity |
| 08/11/2009 | CA2222552C N-oxides as antibacterial agents |
| 08/06/2009 | WO2009096572A1 Process for production of nucleic acid derivative and intermediate compound thereof |
| 08/06/2009 | WO2009095788A1 Substituted arylamide oxazepinopyrimidone derivatives |
| 08/06/2009 | WO2009095787A1 Substituted heteroarylamide oxazepinopyrimidone derivatives |
| 08/06/2009 | WO2009095253A1 6-halo-pyrazolo[1, 5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mglur) modulators |
| 08/06/2009 | US20090198051 Chemical intermediates for sulfiding under mild conditions forming ring compounds for use as marine alkaloids; connecting reaction of 4 components, transforming c22-tert-butyltriphenylsilyl to acety group, cyclization, hydroxy group to methanesulonyl group, reduction of amide, dehydration,Heck reaction |
| 08/06/2009 | US20090197940 CHONDROPSIN-CLASS ANTITUMOR V-ATPase INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF |
| 08/06/2009 | US20090197877 Antibacterial Compositions |
| 08/06/2009 | CA2713253A1 Substituted arylamide oxazepinopyrimidone derivatives |
| 08/06/2009 | CA2713248A1 Substituted heteroarylamide oxazepinopyrimidone derivatives |
| 08/05/2009 | EP2085400A1 Substituted heteroarylamide oxazepinopyrimidone derivatives |
| 08/05/2009 | EP2085399A1 substituted arylamide oxazepinopyrimidone derivatives |
| 08/05/2009 | EP1805144A4 Heterocyclical chromophore architectures |
| 08/05/2009 | EP1399445B1 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 08/05/2009 | CN101501009A CGRP receptor antagonists |
| 08/05/2009 | CN101497619A Method for the manufacture of THIP |
| 08/05/2009 | CN101497612A Novel carbostyrile compound, preparation and use |
| 08/05/2009 | CN100522972C Fused heterocyclic isoxazoline derivatives and their use as anti-depressants |
| 08/05/2009 | CN100522971C Method for synthesizing oxazole pyridone compound |
| 08/05/2009 | CN100522967C Phosphorus-containing compounds & uses thereof |
| 08/05/2009 | CN100522960C Thioamide derivatives as progesterone receptor modulators |
| 08/05/2009 | CN100522161C (Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor |
| 08/04/2009 | US7569580 Tetrazolo[1,5-a]thieno[2,3-e]pyridine-4-carboxylic acid |
| 08/04/2009 | US7569561 For treating carcinoma chosen from cervical, breast, colon, head and neck, lung, pancreas, prostate, sarcomas, leukaemias, lymphomas, melanomas and gliomas |
| 08/04/2009 | US7569517 4-biphenyl-substituted pyrazolidin-3 5-diones pesticide agent and/or microbicide and/or herbicide |
| 08/04/2009 | CA2506081C Water-soluble mesoporphyrin compounds and methods of preparation |
| 07/30/2009 | WO2009093747A1 Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them |
| 07/30/2009 | WO2009092764A1 Compounds comprising a cyclobutoxy group |
| 07/30/2009 | WO2009073534A3 Bicyclic ppat inhibitors as antibacterial agents |
| 07/30/2009 | WO2009055331A3 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119 |
| 07/30/2009 | US20090192149 Imidazo Compounds |
| 07/30/2009 | US20090192145 Spiro-Imidazo Compounds |
| 07/30/2009 | US20090192144 Imidazo Compounds |
| 07/30/2009 | CA2712347A1 Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them |
| 07/30/2009 | CA2710474A1 Compounds comprising a cyclobutoxy group |
| 07/29/2009 | EP2083014A2 Inhibitors of interleukin-1ß converting enzyme |
| 07/29/2009 | EP1753748B1 Proline derivatives and their use as dipeptidyl peptidase iv inhibitors |
| 07/29/2009 | CN101492462A Benzimidazole derivative containing isoxazole-pyridine |
| 07/29/2009 | CN101492461A Benzimidazole derivative containing alkoxyl oxygen alkyl ethyl substituted pyridine-tetrahydrochysene isoxazole |
| 07/29/2009 | CN101492460A Benzimidazole derivative containing alkoxyl oxygen alkyl substituted pyridine-tetrahydrochysene isoxazole |
| 07/29/2009 | CN101492459A Compound containing alcoxyl acetyl dihydrogen isoxazole-pyridine |
| 07/28/2009 | US7566778 Central nervous system disorders; psychological disorders |
| 07/28/2009 | US7566725 2-(4-methylphenyl),3-(thien-2-yl-carbonyl),6-(methyl)imidazo(1,2-a)pyridine; GABA receptor inhibitors; anxiiolytic agents; sleep disorders (insomnia); psychological disorders; anticonvulsants; aggressiveness; antispasmodic agents; antidepressants/ bipolar disorders;cognition activators; analgesics |
| 07/28/2009 | US7566707 For example, 2-[3-(Tert-butyloxycarbonylamino)-piperidin-1-yl]-3-(2-butyn-1-yl)-5-[(dibenzo[b,f][1,4]-oxazepin-11-yl)methyl]-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one; inhibiting effect on activity of the enzyme dipeptidylpeptidase-IV; use in treatment of diabetes mellitus, arthritis, obesity |
| 07/28/2009 | US7566706 Drug delivery methods of 17-ammonium hydroquinone ansamycin analogs with improved solubility and air stability; antiproliferative and anticarcinogenic agents |
| 07/28/2009 | CA2447329C 1-oxa-3,9-diaza-spiro[5,5]undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor |
| 07/23/2009 | WO2009091594A1 Crystalline forms of lestaurtinib |
| 07/23/2009 | WO2009091374A2 Fused heterocyclic derivatives and methods of use as c-met inhibitors |
| 07/23/2009 | WO2009090548A2 3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands |
| 07/23/2009 | WO2009063061A3 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 07/23/2009 | WO2009001214A3 Thieno[2,3-d]pyrimidin-4(3h)-one, isoxazolo[5,4-d]pyrimidin-4(5h)-one and isothiazolo[5,4-d]pyrimidin-4(5h)-one derivatives as calcium receptor antagonists |
| 07/23/2009 | WO2008096001A8 Hcv inhibiting macrocyclic phenylcarbamates |
| 07/23/2009 | US20090187028 Process for preparing Chiral Dipeptidyl Peptidase -IV Inhibitor Intermediates |
| 07/23/2009 | US20090186871 Tyrosine kinase inhibitors |
| 07/23/2009 | US20090186378 recombinant vectors encoding the FK-520 polyketide synthase and FK-520 modification enzymes can be used to produce the FK-520 polyketide; for immunosuppression or to stimulate nerve growth and regeneration |
| 07/23/2009 | DE4418115B4 Galenische Formulierungen Pharmaceutical formulations |
| 07/23/2009 | CA2710374A1 Fungicide hydroximoyl-tetrazole derivatives |
| 07/22/2009 | EP2079748A1 A pure form of rapamycin and a process for recovery and purification thereof |
| 07/22/2009 | EP2079704A2 Therapeutic compounds |
| 07/22/2009 | EP2079480A2 Hcv ns3 protease inhibitors |
| 07/22/2009 | EP2079472A2 High-purity large-scale preparation of stannsoporfin |
| 07/22/2009 | EP1391456B1 2-iminoimidazole derivatives |
| 07/22/2009 | CN101490060A Mtki喹唑啉衍生物 Mtki quinazoline derivatives |
| 07/22/2009 | CN101486716A Preparation of good quality benemicin |
| 07/22/2009 | CN101486715A Novel oxazine compound and use for preventing platelet aggregation |
| 07/22/2009 | CN101486714A Novel oxazine compound and use for preventing platelet aggregation |
| 07/22/2009 | CN100516066C Compounds for treating impaired fundic relaxation |
| 07/22/2009 | CN100516061C Pyridine derivatives as NMDA receptor ligands |
| 07/21/2009 | US7563892 Autoimmune diseases; water solubility of prodrug can be tailored to improve bioavailability using substution at amine groups; inhibitors of degranulation of immune cells; inhibit/activate Fc receptor signaling cascades; treatment of pyridinediamine compound with base, then acid |
| 07/21/2009 | US7563877 Macrolide antibiotics; active against Macrolides-Lincosamides-type B Streptogramines; reduction, chlorination, |
| 07/21/2009 | CA2367921C Bicyclic heterocycles, processes for their preparation and their use as herbicides and pharmaceutical agents |
| 07/16/2009 | WO2009089057A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 07/16/2009 | WO2009087153A1 Tricyclic nitrogen compounds and their use as antibacterial agents |
| 07/16/2009 | US20090181996 Substituted quinolones iii |
| 07/16/2009 | US20090181958 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions |
| 07/16/2009 | US20090181955 Antibacterial Agents |
| 07/16/2009 | US20090181947 Bicyclic enamino(thio)carbonyl compounds |
| 07/16/2009 | US20090181945 Two cyclic cinnamide compound |
| 07/16/2009 | US20090181942 Tricyclic compounds |
| 07/16/2009 | US20090180985 Bridged carbocyclic oxime hepatitis c virus serine protease inhibitors |
| 07/16/2009 | CA2707441A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 07/15/2009 | EP2078027A1 Cathepsin proteases inhibitors |
| 07/15/2009 | EP2078026A1 Prodrug salts of 2, 4-pyrimidinediamine compounds and their uses |
| 07/15/2009 | EP2078016A2 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 07/15/2009 | EP1863774A4 Heterocyclical chromophore architectures with novel electronic acceptor systems |
| 07/15/2009 | EP1458726B1 Mitotic kinesin inhibitors |
| 07/15/2009 | CN101481382A Preparation of 27-demethyl sirolimus |
| 07/15/2009 | CN101481381A Method for preparing ciprofloxacin by piperazine reaction |
| 07/14/2009 | US7560546 Tyrosine kinase inhibitors |
| 07/14/2009 | US7560466 N4-(2,2-Dimethyl-3-oxo-4H-5-pyrid[1,4]oxazin-6-yl)-N2-(3-chloro-4-methoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE (Fc epsilon RI) and IgG (Fc gamma RI) antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis |
| 07/14/2009 | US7560457 E.g., 9,27-dihydroxy-3-{2-[4-hydroxy-3-methoxycyclohexyl]-1-methylethyl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-37-phenyl 4,9,10,12,13,14,15,18,21,22,23,24,25,26,27,32,33,34,34a-nonadecahydro-3H-23,27-epoxy-18,15-(epoxyimino)pyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(6H,31H)-pentone |
| 07/14/2009 | US7560454 1-(4-(10,11-dihydro-5H-pyrrolo[2,1-c](1,4)benzodiazepine-10-ylcarbonyl)-2-methyl-benzylcarbamoyl)-4methoxy-L-proline-N,N-dimethylamide; vasopressin agonists particularly useful in the treatment of urogenital disorders central diabetes insipidus, nocturnal enuresis and nocturia; blood disorders |